LATAM RIS and PACS Market Size, Growth and Forecast 2032

LATAM RIS and PACS market size was valued at USD 342.0 million in 2024 and is projected to reach USD 646.3 million by 2032.

By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Specialty Centers, Research & Academic Institutions, Others); By Application (Patient Registration & Scheduling, Billing & Reporting, Integration with Imaging Modalities, Diagnostic Review and Reporting, Others); By Product Type (Radiology Information System (RIS) - Hardware, Radiology Information System (RIS) - Software, Radiology Information System (RIS) - Services, Picture Archiving and Communication System (PACS) - Hardware, Picture Archiving and Communication System (PACS) - Software, Picture Archiving and Communication System (PACS) - Services); By Region (within LATAM) (Brazil, Mexico, Argentina, Peru, Colombia, Chile, Central America, Rest of LATAM)

SKU: CR2798Report Pages: 250Category: HealthcareReport Format: PDF, ExcelLast Updated: Jun 24Author: Dr. Pankaj SharmaReviewed by: Deepti AgrawalPreferred on

Market Report Metrics

Revenue, 2024 -
USD 342.0 million
Forecast Year -
2032
CAGR (2024–2032)
8.31%
Report Coverage
Regional
REPORT ATTRIBUTE DETAILS
Historical Period  2020-2023
Base Year  2024
Forecast Period  2025-2032
LATAM RIS and PACS Market Size 2024  USD 342.0 Million
LATAM RIS and PACS Market, CAGR  8.31%
LATAM RIS and PACS Market Size 2032  USD 646.3 Million

Market Overview:

The LATAM RIS and PACS Market size was valued at USD 211.5 million in 2018 to USD 342.0 million in 2024 and is anticipated to reach USD 646.3 million by 2032, at a CAGR of 8.31% during the forecast period.

The market is driven by a combination of healthcare modernization efforts, rising imaging volumes, and increasing demand for scalable IT solutions. One of the key factors fueling market growth is the push toward digital transformation across hospitals and diagnostic centers, aiming to streamline imaging workflows, reduce manual errors, and improve overall efficiency. The rising prevalence of chronic conditions and the consequent increase in diagnostic imaging procedures have further stressed the need for advanced systems like RIS and PACS that can manage large volumes of patient data effectively. Additionally, cloud-based deployment models are gaining traction due to their cost-effectiveness, scalability, and ability to support remote access-making them particularly appealing in regions with limited physical infrastructure. Technological advancements, such as artificial intelligence (AI), machine learning integration, and real-time analytics, are also reshaping the market, enabling better diagnostic accuracy and decision-making.

Regionally, the LATAM RIS and PACS market is characterized by varied levels of adoption and infrastructure readiness. Brazil, Mexico, and Argentina lead the market, accounting for a major share due to their relatively mature healthcare IT ecosystems, growing investments in digital health, and the presence of international and domestic vendors. These countries have shown consistent growth in healthcare spending and have adopted national strategies to digitize medical imaging systems. Chile, Colombia, and Peru represent emerging markets where digital health adoption is on the rise, driven by the need to expand access to diagnostic services, especially in underserved areas. While infrastructure gaps and budget constraints continue to pose challenges in some regions, there is a clear shift toward adopting cloud-based solutions to bypass traditional IT limitations. In contrast, countries in Central America and smaller economies in South America are in earlier stages of PACS and RIS adoption.

Market Insights:

  • The LATAM RIS and PACS Market grew from USD 211.5 million in 2018 to USD 342.0 million in 2024 and is projected to reach USD 646.3 million by 2032, registering a CAGR of 8.31%.
  • Healthcare modernization, rising imaging volumes, and the demand for scalable IT infrastructure continue to drive adoption across hospitals and diagnostic centers.
  • Cloud-based deployment models are expanding rapidly due to their affordability, ease of access, and lower infrastructure requirements, especially in resource-limited regions.
  • Technological advancements, including AI integration and real-time analytics, are transforming RIS and PACS into intelligent diagnostic platforms, reducing errors and improving workflow efficiency.
  • Government-led digital health initiatives in countries like Brazil, Mexico, and Argentina are accelerating adoption through policy support, standardization, and financial incentives.
  • Infrastructure disparities and limited IT readiness in rural and public sectors remain key barriers, slowing adoption in smaller economies and underserved areas.
  • Regulatory complexity and concerns around data privacy and cybersecurity continue to challenge vendors, prolonging implementation cycles and limiting market penetration in certain countries.

LATAM RIS and PACS Market Size

Market Drivers:

Rising Demand for Diagnostic Imaging Fuels System Adoption

The growing burden of chronic diseases and aging populations across Latin America has led to a surge in diagnostic imaging procedures. Hospitals and diagnostic centers are increasingly adopting RIS and PACS to manage higher imaging volumes and improve patient care coordination. Traditional manual systems are no longer sufficient to handle the complexity and scale of imaging data, pushing healthcare providers toward integrated digital solutions. The LATAM RIS and PACS Market benefits from this trend, with institutions seeking to streamline radiology workflows and improve turnaround times for clinical decisions. It supports clinicians in reducing redundancy, enabling faster diagnoses and improving treatment planning. The need for structured image storage and faster retrieval is becoming a priority across urban and semi-urban healthcare facilities.

Government-Led Digital Health Initiatives Create Enabling Environment

Health ministries across Brazil, Mexico, Argentina, and other major LATAM countries are implementing national strategies to enhance digital healthcare infrastructure. These efforts include encouraging hospitals to adopt electronic medical records and centralized imaging systems like RIS and PACS. Public healthcare reforms are focusing on increasing efficiency, minimizing manual errors, and enabling data-driven decision-making across departments. The LATAM RIS and PACS Market benefits from policies that support DICOM standards, cloud adoption, and interoperability across radiology networks. It gains momentum in environments where governments offer incentives or subsidies for technology upgrades. Regulatory frameworks are gradually evolving to accommodate cross-border teleradiology and data sharing, which enhances regional collaboration.

  • For instance, Brazil’s Ministry of Healthhas implemented a cloud-based patient record system in Rio de Janeiro, digitizing over 1 million patient records in just a few months using the VitaHisCare solution based on Microsoft technologies.

Cloud-Based Deployment Offers Scalability and Cost Efficiency

Many healthcare institutions in Latin America face limited IT infrastructure, high upfront costs, and resource constraints. Cloud-based RIS and PACS solutions provide a scalable and affordable alternative to traditional on-premise installations. These systems eliminate the need for extensive hardware investments and reduce maintenance burdens on hospitals. The LATAM RIS and PACS Market is seeing faster adoption in smaller clinics and regional hospitals due to cloud deployment models. It allows secure remote access to images and reports, improving collaboration among specialists across locations. Cloud-enabled platforms also support business continuity, ensuring that imaging services remain uninterrupted even during local infrastructure failures.

Technological Advancements Drive Demand for Intelligent Imaging Systems

Radiology departments are seeking tools that enhance diagnostic accuracy and reduce reporting time. Advanced features such as AI-powered image analysis, speech recognition, and automated workflow management are becoming essential components of modern RIS and PACS. The LATAM RIS and PACS Market is evolving to accommodate these capabilities, offering solutions that go beyond simple image archiving. It supports integration with third-party AI tools and decision-support applications, which improves diagnostic outcomes and reduces radiologist workload. Vendors are investing in feature-rich platforms that enable intelligent image processing and structured reporting. Healthcare providers value systems that deliver both performance and clinical insight in a single interface.

  • For example, Pixeon Aurora PACSintegrates AI-powered features such as automatic segmentation of breast masses for mammography, detection of lung opacities in chest X-rays, bone age calculation, and sarcopenia analysis. These tools directly increase diagnostic accuracy and reporting speed, supporting radiologists in high-volume environments and reducing workload through automation.

Integration of Artificial Intelligence Enhances Diagnostic Capabilities

Hospitals and imaging centers across Latin America are incorporating AI tools to improve accuracy and efficiency in radiology workflows. AI algorithms support radiologists by detecting anomalies, prioritizing cases, and automating measurements. These capabilities are helping reduce diagnostic errors and streamline interpretation time for high-volume imaging departments. The LATAM RIS and PACS Market is evolving to support AI integration within existing systems, enabling seamless data exchange between imaging platforms and intelligent applications. It allows healthcare providers to use structured reports, decision-support tools, and predictive analytics directly within the RIS/PACS interface. This trend reflects a shift toward data-driven radiology and precision diagnostics.

  • For instance, Sectra’s solution integrates AI applications directly into radiology workflows via the Sectra Amplifier Marketplace, which serves as a centralized point for contracting, purchasing, and servicing validated AI tools.

Cloud and Web-Based Platforms Gain Momentum Across Healthcare Facilities

Latin American healthcare providers are moving toward cloud-based and web-enabled RIS and PACS solutions due to their lower capital investment and operational flexibility. These platforms allow secure image access from multiple sites, improve disaster recovery, and enable remote reporting. Cloud adoption is rising not only in urban centers but also in smaller regions where physical infrastructure remains limited. The LATAM RIS and PACS Market is benefiting from the scalability and affordability of these solutions, especially for mid-sized hospitals and diagnostic chains. It helps providers maintain continuity of care without relying on high-maintenance, in-house servers. Vendors are offering customizable, subscription-based models to meet diverse organizational needs.

  • For example, GE Healthcare, for example, has deployed cloud-based PACS solutions that improve diagnostic speed and enable remote access critical for Latin American providers expanding telemedicine and teleradiology services

Focus on Interoperability Strengthens Hospital IT Ecosystems

Healthcare institutions in the region are prioritizing systems that support interoperability with electronic medical records (EMR), laboratory systems, and other hospital information platforms. Seamless data exchange improves care coordination, reduces duplication, and allows for centralized patient records. The LATAM RIS and PACS Market is aligning with this trend by offering open-architecture solutions that comply with global standards such as DICOM and HL7. It enables healthcare professionals to access imaging data alongside clinical notes and lab results through a unified interface. This integration enhances diagnostic decision-making and supports multi-disciplinary care approaches. Interoperable systems also prepare institutions for future regulatory compliance and data-sharing requirements.

Mobile Access and Remote Diagnostics Expand Reach of Imaging Services

Mobile accessibility and remote diagnostics are becoming essential in Latin America, where geographic and economic disparities affect healthcare delivery. Providers are adopting RIS and PACS systems that allow radiologists to access, review, and report images through mobile devices and web portals. This supports faster turnaround in underserved areas and enables collaboration with specialists across regions. The LATAM RIS and PACS Market is witnessing increased demand for mobile-compatible solutions that ensure secure, real-time access. It extends imaging capabilities beyond traditional hospital settings, supporting teleradiology and second-opinion services. This trend is reshaping radiology workflows and expanding access to specialized care.

Market Challenges Analysis:

Infrastructure Gaps and Limited IT Readiness Hinder Adoption in Rural and Public Sectors

Many healthcare institutions across Latin America, especially in rural and low-income areas, face persistent infrastructure limitations that delay the deployment of advanced radiology systems. Limited internet connectivity, outdated hardware, and insufficient technical support reduce the feasibility of implementing cloud-based or enterprise-grade RIS and PACS platforms. The LATAM RIS and PACS Market is affected by this uneven readiness, which slows the pace of digital transformation outside major urban centers. It also creates disparities in diagnostic capabilities between public and private healthcare providers. Budget constraints in government-funded hospitals further restrict investments in scalable, interoperable systems. Without adequate infrastructure, these institutions struggle to meet growing imaging demands or maintain continuity in patient care.

Regulatory Complexity and Data Security Concerns Impact Market Growth

The region's fragmented regulatory landscape presents challenges for consistent RIS and PACS adoption. Countries vary in their standards for medical data exchange, patient privacy, and health IT certifications, making it difficult for vendors to deliver region-wide solutions. The LATAM RIS and PACS Market must navigate diverse compliance requirements while ensuring data integrity and confidentiality. It faces rising concerns over cybersecurity, particularly with cloud-based platforms that involve remote access and external hosting. Some providers remain hesitant to shift from legacy systems due to perceived data risks or unclear legal protections. These challenges increase implementation timelines and raise the cost of compliance, slowing market penetration in key segments.

Market Opportunities:

Rising Investments in Healthcare Infrastructure Unlock New Deployment Potential

Governments and private investors are increasing funding to modernize hospitals and diagnostic centers across Latin America. These investments create favorable conditions for implementing advanced imaging IT solutions. The LATAM RIS and PACS Market can benefit from projects focused on expanding healthcare access, especially in underserved regions. It presents opportunities for vendors to offer scalable systems tailored to diverse institutional needs. Solutions that combine cloud deployment, mobile access, and AI support are well-positioned to meet this demand. The market stands to grow by aligning with national healthcare transformation agendas.

Growing Demand for Teleradiology and Remote Diagnostics Expands Market Scope

The adoption of teleradiology is gaining traction in Latin America due to the shortage of radiologists and the need to extend diagnostic services beyond major cities. The LATAM RIS and PACS Market can leverage this shift by offering platforms that support secure remote image access and reporting. It can play a vital role in facilitating cross-regional collaboration and second-opinion services. Vendors that enable mobile compatibility and real-time data sharing will be better equipped to capture this opportunity. Teleradiology also supports healthcare continuity in remote and emergency settings. This trend broadens the market’s relevance across varied healthcare delivery models.

Market Segmentation Analysis:

The LATAM RIS and PACS Market is segmented by product type, application, and end user, reflecting the diverse needs of healthcare providers across the region.

By product type, Radiology Information System (RIS) is divided into hardware, software, and services. Software dominates due to rising demand for workflow automation and integration with EMRs. Picture Archiving and Communication System (PACS) also includes hardware, software, and services, with software leading adoption because of its role in image storage, retrieval, and sharing.

  • For example, RamSoftoffers cloud-based RIS and PACS solutions where software is central to workflow automation, image storage, retrieval, and sharing. Their PowerServer RIS/PACS is built on a single, unified database, providing seamless integration with EMRs and eliminating the need for costly hardware investments.

By application, the RIS segment covers patient registration & scheduling, billing & reporting, and others. Patient registration & scheduling holds the largest share due to its role in managing patient flow and resource allocation. In PACS, integration with imaging modalities and diagnostic review & reporting are the key applications. Diagnostic review & reporting leads due to increasing imaging volumes and the need for timely interpretation.

  • For instance, broadly adopted in Spanish-speaking Latin America by both hospitals and imaging centers, Philips Vue PACS is recognized for reliability and minimal downtime, supporting high-volume diagnostic review and reporting needs

By end user, the LATAM RIS and PACS Market serves hospitals & clinics, diagnostic imaging centers, specialty centers, research & academic institutions, and others. Hospitals & clinics dominate the segment, driven by infrastructure development and higher imaging demand. Diagnostic imaging centers follow closely, adopting scalable solutions to improve service efficiency and data management.

Segmentation:

By Product Type

  • Radiology Information System (RIS)
    • Hardware
    • Software
    • Services
  • Picture Archiving and Communication System (PACS)
    • Hardware
    • Software
    • Services

By Application

  • Radiology Information System
    • Patient Registration & Scheduling
    • Billing & Reporting
    • Others
  • Picture Archiving and Communication System
    • Integration with Imaging Modalities
    • Diagnostic Review and Reporting
    • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Specialty Centers
  • Research & Academic Institutions
  • Others

By Region (within LATAM)

  • Brazil
  • Mexico
  • Argentina
  • Peru
  • Colombia
  • Chile
  • Central America
  • Rest of LATAM

Regional Analysis:

Brazil, Mexico, and Argentina Lead Market Expansion Across Latin America

Brazil holds the largest share in the LATAM RIS and PACS Market, accounting for approximately 38% of the regional market. Its advanced hospital networks, public-private healthcare investments, and growing number of diagnostic centers support widespread RIS and PACS adoption. Mexico follows with a 25% share, driven by strong demand from both public health institutions and private imaging chains seeking to digitize operations. Argentina contributes around 15% of the market, supported by academic hospitals and urban diagnostic labs modernizing their radiology infrastructure. The LATAM RIS and PACS Market gains strength from these three countries due to their relatively better infrastructure, stable vendor networks, and early-stage integration of AI-enabled imaging tools. It sees continued growth from cloud-based deployments that reduce IT maintenance costs for smaller institutions.

Emerging Markets Like Chile, Colombia, and Peru Show Strong Growth Potential

Chile, Colombia, and Peru collectively account for nearly 14% of the regional RIS and PACS market and present high growth opportunities. These countries are improving healthcare IT infrastructure, particularly in urban areas, through strategic health modernization plans. Cloud-based RIS and PACS systems are becoming attractive in these regions due to limited in-house IT resources and high scalability requirements. The LATAM RIS and PACS Market benefits from local government interest in enhancing diagnostic access in remote areas, which fuels interest in mobile-compatible and web-based platforms. It also reflects vendor efforts to expand footprint in secondary cities where adoption remains low but demand is rising. Partnerships between healthcare providers and regional IT firms help tailor solutions to local regulatory and workflow needs.

Rest of Latin America Offers Long-Term Potential Despite Infrastructure Gaps

Central America and smaller South American nations, including Ecuador, Bolivia, and Paraguay, hold the remaining 8% of the LATAM RIS and PACS Market. Adoption remains limited due to financial constraints, fragmented healthcare delivery, and low IT readiness in public facilities. However, market potential exists as these countries invest in basic digitization and telemedicine capabilities. It gains relevance in small-scale hospitals looking for low-cost, cloud-based platforms that can integrate with basic EMR systems. Vendors that offer simplified, modular solutions with strong remote support can position themselves competitively in these underserved areas. Market maturity remains low but signals opportunity for long-term expansion through targeted education, training, and infrastructure development.

Key Player Analysis:

  • Allscripts Healthcare Solutions, Inc.
  • Hoffmann-La Roche Ltd
  • Carestream Health, Inc.
  • Cerner Corporation
  • Epic Systems Corporation
  • Merge Healthcare Incorporated
  • GE Healthcare
  • Brit Systems
  • Pixeon
  • Other Key Players

Competitive Analysis:

The LATAM RIS and PACS Market features a mix of global and regional players competing on technology, customization, and service support. Leading companies such as GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm, and Agfa-Gevaert dominate with strong brand presence and scalable enterprise solutions. Regional vendors, including Pixeon and Novarad Latin America, offer cost-effective and localized platforms tailored to mid-sized hospitals and diagnostic centers. The LATAM RIS and PACS Market sees rising demand for cloud-based, AI-integrated, and interoperable systems, driving vendors to innovate in user interface design, mobile accessibility, and data security. It favors companies that provide flexible deployment models and strong after-sales service. Strategic partnerships with healthcare institutions and IT providers remain critical for market expansion. Competitive advantage depends on the ability to deliver seamless integration with EMRs, meet regional compliance standards, and adapt to variable infrastructure capabilities across Latin American countries.

LATAM RIS and PACS Market Segmentation

Recent Developments:

  • In March 2025, F. Hoffmann-La Roche AG entered into the largest ever single asset partnership with Zealand Pharma A/S, valued at up to $5.3 billion. This deal focuses on co-developing and co-commercializing petrelintide monotherapy and potential combination products for obesity treatment, mainly targeting the U.S. and European markets. Although not directly tied to RIS or PACS, this partnership demonstrates Roche’s continued investment in healthcare collaborations and innovation.
  • In June 2024, Carestream Health secured a crucial business partner agreement in Peru with Distribuidora Diagnostica Medica SAC (DMD). Under this partnership, DMD became an exclusive distributor for Carestream in the region, purchasing 80 DryView printers with significant projected print volumes for 2024 and beyond.

Market Concentration & Characteristics:

The LATAM RIS and PACS Market is moderately concentrated, with a few global players holding a significant share alongside several regional vendors offering tailored solutions. It features a competitive landscape shaped by product differentiation, deployment flexibility, and service reliability. Leading companies such as GE Healthcare, Philips, Siemens Healthineers, and Fujifilm dominate the high-end segment, while local providers like Pixeon and Novarad address the needs of mid-sized and public hospitals. The market favors vendors that offer scalable, cloud-based platforms with strong integration capabilities and localized support. It is characterized by growing demand for interoperability, mobile access, and AI-enhanced tools, which drive innovation across offerings. Vendors that adapt to varied infrastructure levels and compliance requirements maintain a strong position in this dynamic environment.

Report Coverage:

The research report offers an in-depth analysis based on product type, application, and end user. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

  • Increased adoption of cloud-based RIS and PACS solutions will drive cost efficiency and scalability across mid-sized and rural healthcare facilities.
  • Government-backed healthcare digitization programs are expected to accelerate system implementation in public hospitals.
  • AI-integrated imaging platforms will gain traction, improving diagnostic accuracy and reducing radiologist workload.
  • Mobile compatibility and remote access capabilities will expand imaging services in underserved regions.
  • Local vendors offering customizable, low-cost solutions will strengthen their presence in secondary markets.
  • Interoperability with EMRs and other clinical systems will become a standard requirement for procurement.
  • Teleradiology demand will grow, supporting cross-border diagnostics and regional collaboration.
  • Private healthcare investments will rise, especially in urban centers, increasing system upgrades.
  • Strategic partnerships between technology providers and healthcare networks will drive integrated solutions.
  • Vendor success will depend on offering secure, scalable platforms that comply with evolving data protection regulations.
LATAM RIS and PACS Market Size, Growth and Forecast 2032
Report Attribute Details
Details
Historical Period
-
Base Year
2024
Forecast Period
2024–2032
LATAM RIS and PACS Size 2024
USD 342.0 million
LATAM RIS and PACS CAGR
8.31%
LATAM RIS and PACS Size 2032
USD 646.3 million

Request a Free Sample

Fill in your details and we'll send you a free sample report.

  • Sample data tables & charts
  • Research methodology

Market Dynamics

Healthcare Modernization and Digital Transformation

Ongoing efforts to modernize healthcare infrastructure across Latin America are driving the adoption of RIS and PACS, as hospitals and diagnostic centers seek to digitize workflows, reduce manual errors, and improve operational efficiency.

Government-Led Digital Health Initiatives

National strategies and public healthcare reforms in countries like Brazil, Mexico, and Argentina are incentivizing the adoption of centralized imaging systems, supporting DICOM standards, and promoting interoperability, which accelerates RIS and PACS implementation.

Cloud-Based Deployment and Scalability

The shift toward cloud-based RIS and PACS solutions is enabling healthcare providers, especially in resource-limited and rural areas, to access scalable, cost-effective imaging IT without heavy upfront investments in hardware and maintenance.

Rising Imaging Volumes Due to Chronic Disease Burden

The increasing prevalence of chronic diseases and aging populations is leading to higher diagnostic imaging volumes, necessitating advanced systems that can efficiently manage, store, and retrieve large amounts of imaging data.

Technological Advancements and AI Integration

The integration of artificial intelligence, machine learning, and real-time analytics into RIS and PACS platforms is enhancing diagnostic accuracy, reducing radiologist workload, and enabling intelligent workflow automation, making these systems more attractive to healthcare providers.

Need a Custom Version of This Report?

Tailor the scope, geography, or segments to your exact requirements.

  • Custom geography or segment scope
  • Direct access to our analyst team

Frequently Asked Questions

What is the current size of the LATAM RIS and PACS Market?
The LATAM RIS and PACS Market was valued at USD 342.0 million in 2024 and is expected to reach USD 646.3 million by 2032, growing at a CAGR of 8.31%.
What factors are driving the growth of the LATAM RIS and PACS Market?
Growth is driven by healthcare modernization, increasing diagnostic imaging volumes, rising demand for scalable IT solutions, and the shift toward digital transformation in hospitals.
What are the key segments within the LATAM RIS and PACS Market?
Key segments include cloud-based vs. on-premise deployment, integration with EMRs, AI-enabled platforms, and public vs. private healthcare applications.
What are some challenges faced by the LATAM RIS and PACS Market?
Infrastructure gaps, limited IT readiness in rural areas, budget constraints in public healthcare, and regulatory variability across countries are major challenges.
Who are the major players in the LATAM RIS and PACS Market?
Leading players include GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm, Pixeon, and Novarad Latin America.

Table of Content

Chapter 1 Market Segmentation

  • 1.1 Segmentation Framework
    • 1.1.1 Product and Service Classification
    • 1.1.2 Application and End-Use Classification
    • 1.1.3 Technology and Solution Classification
    • 1.1.4 Customer and Distribution Channel Classification
    • 1.1.5 Geographic Segmentation
    • 1.1.6 Market Segment Definitions and Boundaries
  • 1.2 By End User
    • 1.2.1 Hospitals & Clinics
    • 1.2.2 Diagnostic Imaging Centers
    • 1.2.3 Specialty Centers
    • 1.2.4 Research & Academic Institutions
    • 1.2.5 Others
  • 1.3 By Application
    • 1.3.1 Patient Registration & Scheduling
    • 1.3.2 Billing & Reporting
    • 1.3.3 Integration with Imaging Modalities
    • 1.3.4 Diagnostic Review and Reporting
    • 1.3.5 Others
  • 1.4 By Product Type
    • 1.4.1 Radiology Information System (RIS) - Hardware
    • 1.4.2 Radiology Information System (RIS) - Software
    • 1.4.3 Radiology Information System (RIS) - Services
    • 1.4.4 Picture Archiving and Communication System (PACS) - Hardware
    • 1.4.5 Picture Archiving and Communication System (PACS) - Software
    • 1.4.6 Picture Archiving and Communication System (PACS) - Services
  • 1.5 By Region (within LATAM)
    • 1.5.1 Brazil
    • 1.5.2 Mexico
    • 1.5.3 Argentina
    • 1.5.4 Peru
    • 1.5.5 Colombia
    • 1.5.6 Chile
    • 1.5.7 Central America
    • 1.5.8 Rest of LATAM

Chapter 2 Introduction

  • 2.1 Report Objectives and Scope
  • 2.2 Product Definition and Industry Terminology
  • 2.3 Market Inclusions and Exclusions
  • 2.4 Research Process
    • 2.4.1 Primary Research and Expert Interviews
    • 2.4.2 Secondary Research and Source Review
    • 2.4.3 Top-Down and Bottom-Up Estimation
    • 2.4.4 Data Triangulation and Verification
  • 2.5 Market Size Measurement Basis
    • 2.5.1 2024: USD 342.0 million → 2032: USD 646.3 million
  • 2.6 Historical and Forecast Reference Periods
    • 2.6.1 Base Year: 2024
    • 2.6.2 Forecast Period: 2024-2032
  • 2.7 Research Assumptions and Limitations

Chapter 3 Executive Summary

  • 3.1 Market Snapshot and Key Findings
  • 3.2 Base-Year Market Size, 2024
  • 3.3 Forecast Market Size, 2032
  • 3.4 Revenue and Volume Growth Outlook
  • 3.5 Key Demand and Supply Indicators
  • 3.6 Leading Market Segments
  • 3.7 Fastest-Growing Market Opportunities
  • 3.8 Regional Performance Highlights
  • 3.9 Technology and Industry Transformation
  • 3.10 Competitive Landscape Summary
  • 3.11 Analyst View and Strategic Implications

Chapter 4 LATAM RIS and PACS Market Trends and Developments

  • 4.1 Historical Industry Development
  • 4.2 Recent Market Trends and Developments
  • 4.3 Demand and Customer Behavior Trends
  • 4.4 Technology and Product Innovation
  • 4.5 Artificial Intelligence, Automation and Digitalization
  • 4.6 Local Manufacturing and Supply Chain Realignment
  • 4.7 Industry Partnerships, Mergers and Acquisitions
  • 4.8 Sustainability and Circular Economy Developments
  • 4.9 Government and Private Sector Investment Trends
  • 4.10 Emerging Business Models and Commercialization
  • 4.11 Industry Developments and Announcements

Chapter 5 LATAM RIS and PACS Market Production, Supply and Demand Analysis

  • 5.1 Demand Trend and Consumption Analysis
  • 5.2 Demand Forecast, 2024-2032
  • 5.3 Production and Output Trend
  • 5.4 Production and Output Forecast, 2024-2032
  • 5.5 Installed Capacity and Capacity Utilization
  • 5.6 Company-Wise Production Plants and Statistics
    • 5.6.1 Installed Production Capacity
    • 5.6.2 Actual Production
    • 5.6.3 Planned Capacity and Expansion Targets
  • 5.7 Supply Chain Structure and Procurement Trends
  • 5.8 Supply-Demand Gap and Bottlenecks
  • 5.9 Import Dependence and Sourcing Structure
  • 5.10 Contract Manufacturing and Outsourcing
  • 5.11 Regional Supply and Demand Concentration

Chapter 6 LATAM RIS and PACS Market Pricing Analysis

  • 6.1 Pricing Structure and Measurement
  • 6.2 Historical Pricing Trends
  • 6.3 Pricing Outlook, 2024-2032
  • 6.4 Average Selling Price and Unit Economics
  • 6.5 Pricing by Product and Market Segment
  • 6.6 Geographic Pricing Differences
  • 6.7 Key Input, Energy, Labor and Logistics Costs
  • 6.8 Contract Pricing and Purchasing Models
  • 6.9 Pricing Sensitivity and Competitive Positioning
  • 6.10 Price, Margin and Profitability Implications

Chapter 7 LATAM RIS and PACS Market Dynamics

  • 7.1 Market Growth Drivers
    • 7.1.1 Demand-Side Drivers
    • 7.1.2 Technology and Innovation Drivers
    • 7.1.3 Infrastructure and Investment Drivers
    • 7.1.4 Regulatory and Policy Drivers
  • 7.2 Market Restraints
    • 7.2.1 Cost and Affordability Constraints
    • 7.2.2 Technology and Adoption Barriers
    • 7.2.3 Supply Chain and Operational Constraints
  • 7.3 Market Challenges
    • 7.3.1 Competitive Pressure and Margin Erosion
    • 7.3.2 Skills, Infrastructure and Implementation Gaps
  • 7.4 Emerging Market Opportunities
  • 7.5 Market Dynamics Impact and Time-Horizon Assessment

Chapter 8 LATAM RIS and PACS Value Chain Analysis

  • 8.1 Industry Value Chain Overview
  • 8.2 Upstream Suppliers and Critical Inputs
  • 8.3 Technology and Component Providers
  • 8.4 Manufacturing or Service Delivery
  • 8.5 Distribution, Channel Partners and Integrators
  • 8.6 Downstream Applications and End Users
  • 8.7 Value Addition and Profit Pools
  • 8.8 Vertical Integration and Outsourcing
  • 8.9 Supplier Concentration and Risk
  • 8.10 Supply Chain Localization and Resilience

Chapter 9 LATAM RIS and PACS Market Regulations and Policies

  • 9.1 Relevant Laws, Standards and Compliance Frameworks
  • 9.2 Product, Service, Safety and Quality Requirements
  • 9.3 Government Policies, Incentives and Subsidies
  • 9.4 Imports, Exports and Trade Barriers
  • 9.5 Public Procurement and Local Content Requirements
  • 9.6 Environmental and Sustainability Compliance
  • 9.7 Upcoming Policy Changes and Market Implications

Chapter 10 LATAM RIS and PACS Market Hotspots and Opportunities

  • 10.1 Market Opportunity Mapping and Growth Hotspots
  • 10.2 High-Growth Applications and Customer Groups
  • 10.3 Underserved Markets and White-Space Opportunities
  • 10.4 Emerging Technology and Product Opportunities
  • 10.5 New Capacity and Investment Hotspots
  • 10.6 Market Entry and Expansion Opportunities
  • 10.7 Distribution and Partnership Opportunities
  • 10.8 Near-Term and Long-Term Commercial Potential
  • 10.9 Opportunity Attractiveness and Execution Risks

Chapter 11 LATAM RIS and PACS Market Outlook, 2024-2032

  • 11.1 Market Size and Analysis
    • 11.1.1 Revenue (Market Measurement: 2024: USD 342.0 million → 2032: USD 646.3 million)
    • 11.1.2 Market Volume and Quantity Sold
    • 11.1.3 Historical Market Size
    • 11.1.4 Base-Year Market Size, 2024
  • 11.2 Market Forecast, 2024-2032
    • 11.2.1 Revenue Forecast to 2032
    • 11.2.2 Volume Forecast to 2032
    • 11.2.3 CAGR and Year-on-Year Growth
    • 11.2.4 Incremental Revenue Opportunity
  • 11.3 Forecast Assumptions and Scenario Analysis
    • 11.3.1 Base-Case Forecast
    • 11.3.2 Optimistic and Conservative Scenarios
    • 11.3.3 Technology, Pricing and Policy Sensitivities
  • 11.4 Market Attractiveness and Growth Outlook

Chapter 12 LATAM RIS and PACS Market Segmentation and Outlook

  • 12.1 Segmentation Summary and Market Shares, 2024
  • 12.2 Largest and Fastest-Growing Segments
  • 12.3 By End User - Market Size and Forecast, 2024-2032
    • 12.3.1 Segment Definition and Scope
    • 12.3.2 Historical Market Size
    • 12.3.3 Revenue Forecast, 2024-2032
    • 12.3.4 Volume Forecast, 2024-2032
    • 12.3.5 Base-Year Market Share, 2024
    • 12.3.6 Segment CAGR and Growth Drivers
    • 12.3.7 Subsegment Market Size and Forecast
      • 12.3.7.1 Hospitals & Clinics
      • 12.3.7.2 Diagnostic Imaging Centers
      • 12.3.7.3 Specialty Centers
      • 12.3.7.4 Research & Academic Institutions
      • 12.3.7.5 Others
    • 12.3.8 Subsegment Pricing and Adoption Trends
    • 12.3.9 Leading Suppliers and Competition
    • 12.3.10 Regional Demand and Opportunities
  • 12.4 By Application - Market Size and Forecast, 2024-2032
    • 12.4.1 Segment Definition and Scope
    • 12.4.2 Historical Market Size
    • 12.4.3 Revenue Forecast, 2024-2032
    • 12.4.4 Volume Forecast, 2024-2032
    • 12.4.5 Base-Year Market Share, 2024
    • 12.4.6 Segment CAGR and Growth Drivers
    • 12.4.7 Subsegment Market Size and Forecast
      • 12.4.7.1 Patient Registration & Scheduling
      • 12.4.7.2 Billing & Reporting
      • 12.4.7.3 Integration with Imaging Modalities
      • 12.4.7.4 Diagnostic Review and Reporting
      • 12.4.7.5 Others
    • 12.4.8 Subsegment Pricing and Adoption Trends
    • 12.4.9 Leading Suppliers and Competition
    • 12.4.10 Regional Demand and Opportunities
  • 12.5 By Product Type - Market Size and Forecast, 2024-2032
    • 12.5.1 Segment Definition and Scope
    • 12.5.2 Historical Market Size
    • 12.5.3 Revenue Forecast, 2024-2032
    • 12.5.4 Volume Forecast, 2024-2032
    • 12.5.5 Base-Year Market Share, 2024
    • 12.5.6 Segment CAGR and Growth Drivers
    • 12.5.7 Subsegment Market Size and Forecast
      • 12.5.7.1 Radiology Information System (RIS) - Hardware
      • 12.5.7.2 Radiology Information System (RIS) - Software
      • 12.5.7.3 Radiology Information System (RIS) - Services
      • 12.5.7.4 Picture Archiving and Communication System (PACS) - Hardware
      • 12.5.7.5 Picture Archiving and Communication System (PACS) - Software
      • 12.5.7.6 Picture Archiving and Communication System (PACS) - Services
    • 12.5.8 Subsegment Pricing and Adoption Trends
    • 12.5.9 Leading Suppliers and Competition
    • 12.5.10 Regional Demand and Opportunities
  • 12.6 By Region (within LATAM) - Market Size and Forecast, 2024-2032
    • 12.6.1 Segment Definition and Scope
    • 12.6.2 Historical Market Size
    • 12.6.3 Revenue Forecast, 2024-2032
    • 12.6.4 Volume Forecast, 2024-2032
    • 12.6.5 Base-Year Market Share, 2024
    • 12.6.6 Segment CAGR and Growth Drivers
    • 12.6.7 Subsegment Market Size and Forecast
      • 12.6.7.1 Brazil
      • 12.6.7.2 Mexico
      • 12.6.7.3 Argentina
      • 12.6.7.4 Peru
      • 12.6.7.5 Colombia
      • 12.6.7.6 Chile
      • 12.6.7.7 Central America
      • 12.6.7.8 Rest of LATAM
    • 12.6.8 Subsegment Pricing and Adoption Trends
    • 12.6.9 Leading Suppliers and Competition
    • 12.6.10 Regional Demand and Opportunities
  • 12.7 Segment Growth Comparison
  • 12.8 Segment Attractiveness and Priority Matrix

Chapter 13 LATAM RIS and PACS End-Use and Application Market Outlook

  • 13.1 End-Use Industry and Customer Demand Structure
  • 13.2 Leading Applications and Customer Groups
  • 13.3 End-Use Market Size, Share and Forecast
  • 13.4 Major End-Use Industry Deep Dives
    • 13.4.1 Customer Requirements and Use Cases
    • 13.4.2 Demand and Replacement Cycles
    • 13.4.3 Technical and Regulatory Considerations
    • 13.4.4 Purchasing and Procurement Models
    • 13.4.5 Leading Vendors and Distribution Channels
    • 13.4.6 Forecast and Commercial Opportunities
  • 13.5 Emerging Applications and Cross-Segment Demand
  • 13.6 End-Use Industry Investment Priorities

Chapter 14 LATAM RIS and PACS Geographic Market Outlook, 2024-2032

  • 14.1 Regional Market Size and Country-Level Shares, 2024
  • 14.2 Country Market Size Comparison, 2024
  • 14.3 Country Market Forecasts, 2024-2032
  • 14.4 Subregional Industrial and Demand Clusters
  • 14.5 Intra-Regional Pricing and Cost Differences
  • 14.6 Cross-Border Trade and Supply Networks
  • 14.7 Regional Supply and Demand Balances
  • 14.8 Country Opportunity Comparison and Prioritization

Note: Every listed country is covered on the structure shown under the first country.

Chapter 15 LATAM RIS and PACS Technology, Innovation and Sustainability Outlook

  • 15.1 Technology Landscape and Maturity
  • 15.2 Product, Process and Service Innovation
  • 15.3 AI, Automation and Digital Tools in the Industry
  • 15.4 Technology Adoption and Performance Benchmarking
  • 15.5 Innovation Pipeline and R&D Investment
  • 15.6 Patent and Intellectual Property Trends
  • 15.7 Energy Efficiency and Resource Management
  • 15.8 Sustainability, Recycling and Circularity
  • 15.9 Technology Roadmap, 2024-2032
  • 15.10 Risks of Obsolescence and Technology Substitution

Chapter 16 LATAM RIS and PACS Market Key Strategic Imperatives

  • 16.1 Growth and Market Entry Priorities
  • 16.2 High-Return Products and Segments
  • 16.3 Pricing, Profitability and Cost Optimization
  • 16.4 Technology Investment and Product Differentiation
  • 16.5 Supply Chain Localization and Resilience
  • 16.6 Distribution and Customer Acquisition
  • 16.7 Partnership, Acquisition and Capacity Strategy
  • 16.8 Regional Expansion Priorities
  • 16.9 Short-, Medium- and Long-Term Actions

Chapter 17 Competition Outlook

  • 17.1 Industry Competition Characteristics
  • 17.2 Market Structure and Concentration
  • 17.3 Market Share and Competitive Positioning, 2024
  • 17.4 Company-Wise Revenue and Product Benchmarking
  • 17.5 Production and Service Capacity Benchmarking
  • 17.6 Technology, Pricing and Differentiation
  • 17.7 Regional Footprint and Distribution Strength
  • 17.8 Mergers, Acquisitions and Strategic Alliances
  • 17.9 New Entrants and Competitive Threats
  • 17.10 Porter's Five Forces and Industry Attractiveness
  • 17.11 Competitive Outlook, 2024-2032

Chapter 18 Company Profiles

  • 18.1 Company Coverage and Selection Criteria
  • 18.2 GE Healthcare
    • 18.2.1 Business Description
    • 18.2.2 Company Ownership and Geographic Presence
    • 18.2.3 Product and Service Portfolio
    • 18.2.4 Manufacturing and Operating Footprint
    • 18.2.5 Production Capacity and Expansion Plans
    • 18.2.6 Financial Performance and Investment
    • 18.2.7 Market Share and Competitive Position
    • 18.2.8 Technology and Innovation Capabilities
    • 18.2.9 Strategic Alliances or Partnerships
    • 18.2.10 Recent Developments
    • 18.2.11 Growth Strategy and Outlook
  • 18.3 Philips Healthcare
  • 18.4 Siemens Healthineers
  • 18.5 Fujifilm
  • 18.6 Agfa-Gevaert
  • 18.7 Pixeon
  • 18.8 Novarad Latin America
  • 18.9 Carestream Health
  • 18.10 Merge Healthcare (IBM Watson Health)
  • 18.11 Allscripts Healthcare Solutions
  • 18.12 Other Relevant Market Participants

Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.

Chapter 19 Disclaimer

  • 19.1 Research and Forecast Disclaimer
  • 19.2 Data Source and Estimation Limitations

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.

Methodology

Meet the Team

Dr. Pankaj Sharma
Dr. Pankaj Sharma

Healthcare Domain Expert & Medical Advisor

Dr. Pankaj Sharma is an anesthesiologist and healthcare strategic advisor who reviews epidemiological models, therapeutic market assessments and clinical assumptions at Credence Research Inc, so that quantitative forecasts reflect clinical realities.

Deepti Agrawal

Reviewed by

Deepti Agrawal

Head of Editorial Operations

Related Topics

Contraceptives Drugs and Devices Market Size, Share, Growth and Forecast, 2025-2035

Contraceptives drugs and devices market valued at USD 24.90 billion in 2025, set to reach USD 36.25 billion by 2035 at a 3.83% CAGR as implants gain.

Plant-Based Vaccines Market Size, Share, Growth and Forecast, 2025-2035

Plant-based vaccines market valued at USD 36.4 million in 2025, forecast to reach USD 216.1 million by 2035 at a 19.50% CAGR on flu and animal vaccines.

Bacteriostatic Water for Injection Market Size, Share, Growth and Forecast, 2025-2035

Bacteriostatic water for injection market valued at USD 188.0 million in 2025, forecast to reach USD 346.9 million by 2035 at a 6.32% CAGR.

Radioisotope Market Size, Share, Growth and Forecast, 2025-2035

Radioisotope market valued at USD 6.15 billion in 2025, forecast to reach USD 13.78 billion by 2035 at an 8.40% CAGR as lutetium-177 therapy scales.

Allan Herndon Dudley Syndrome Treatment Market Size, Share, Growth and Forecast, 2025-2035

Allan-Herndon-Dudley syndrome treatment sales were USD 7.4 million in 2025 and reach USD 84.0 million by 2035, a 27.50% CAGR as tiratricol access widens.

North America Cancer Biopsy Market Size, Share, Growth and Forecast, 2025-2035

North America cancer biopsy market valued at USD 4.42 billion in 2025, forecast to hit USD 10.95 billion by 2035 at a 9.50% CAGR as liquid biopsy grows.